Société Internationale d'Urologie Journal
https://siuj.org/index.php/siuj
<p><em>Société Internationale d’Urologie Journal (SIUJ)</em> is an editorially independent journal owned by the Société Internationale d’Urologie and published online six times a year at siuj.org. <em>SIUJ</em> publishes original peer-reviewed research and review articles in all areas of urology. It supports the highest standards of scientific investigation and seeks to promote best practices.</p>Société Internationale d'Urologieen-USSociété Internationale d'Urologie Journal2563-6499<p>The Société International d'Urologie (SIU), which owns and publishes the <em>Société International d'Urologie Journal (SIUJ)</em>, does not require authors of papers published in the journal to transfer copyright. Instead, we ask authors to grant an exclusive licence that allows us to publish the article in <em>SIUJ</em> (and any derivative or related products or publications) and that allows us to sub-license such rights and exploit all subsidiary rights.</p> <p>Authors retain the right to use their own articles for their own non-commercial purposes without seeking explicit permission from SIU.</p> <p>The <em>SIUJ</em> publication licence expressly defines “non-commercial” as “not primarily intended for or directed towards commercial advantage or monetary compensation.” Although no activity is completely disconnected from commercial activity, the following are generally considered to be non-commercial uses:</p> <ul> <li class="show">Reproduction of a reasonable number (no more than 100) of print copies of the published paper for personal use (e.g., sharing with colleagues, including in grant applications).</li> <li class="show">Posting a copy of the published version of the paper on the author’s own or their institution’s website. The article must be accompanied by this statement: ‘This article has been published in the SIUJ: [full citation; link]’.</li> <li class="show">Inclusion of the paper in a course pack, with a maximum of 100 copies to be used in the author’s institution. The copies must include the following acknowledgement: ‘This article has been published in the SIUJ: [full citation; link].’</li> </ul> <p>As the distinction between commercial and non-commercial is not always clear, authors are strongly advised to seek permission from SIU for any use that may be considered to have a commercial aspect.</p> <p>We ask the corresponding author to read the <a href="https://siuj.org/index.php/siuj/licence" target="_blank" rel="noopener"><u>terms of the licence</u></a> and then to grant this exclusive licence on behalf of all authors by indicating agreement to the following statement:</p> <p>The corresponding author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence on a worldwide basis to the SIU and its licensees to permit this article (if accepted) to be published in the SIUJ and any other SIU products and publications and to exploit all subsidiary rights, as set out in our <a href="https://siuj.org/index.php/siuj/licence" target="_blank" rel="noopener"><span style="text-decoration: underline;">licence agreement</span></a>.</p> <h2>Review and Decision</h2> <p>Most submissions will be reviewed by a senior editor within 2 weeks. Many manuscripts will be rejected at this point for a variety of reasons, including subject matter outside the scope of the <em>SIUJ</em>, flawed design, discredited or outdated methodology, poor organization or presentation, failure to conform to ethical requirements, and apparent plagiarism.The remaining manuscripts will be sent for peer review. The <em>SIUJ</em> uses a single-blind process: reviewers know the identity of the authors, but the authors are not told who has reviewed their manuscript, and <em>SIUJ</em> ensures that potentially identifying information is removed from comments sent to them. Reviewers are asked to make their recommendations within 10 days, after which a senior/specialist editor will consider their comments and recommend provisional acceptance dependent on satisfactory revision, acceptance without revision, or rejection. Authors should receive a final decision within 4 to 6 weeks of submission.</p> <p> </p>Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting; Bladder Cancer
https://siuj.org/index.php/siuj/article/view/323
<p>None.</p>Alexandra Masson-Lecomte
Copyright (c)
2024-11-042024-11-044110.48083//ODUS7848Proceedings from the SIU B2B Uro-Oncology: Prostate Cancer
https://siuj.org/index.php/siuj/article/view/324
<p>None.</p>Derya Tilki
Copyright (c)
2023-01-182023-01-184110.48083//LOGZ8751Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting: GU Cancers Talk Financial Toxicity
https://siuj.org/index.php/siuj/article/view/325
<p>None.</p>Sarah P. Psutka
Copyright (c)
2024-11-042024-11-044110.48083//FSRA7824Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting: Kidney Cancer
https://siuj.org/index.php/siuj/article/view/326
<p>None.</p>Simon Tanguay
Copyright (c)
2024-11-042024-11-044110.48083//JRWC5449Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting: Five Practice-Changing Advances on the Horizon
https://siuj.org/index.php/siuj/article/view/327
<p>None.</p>Sarah P. Psutka
Copyright (c)
2024-11-042024-11-044110.48083//NNCH5444